Credits: this summary of the impact of HIV among Hispanics/Latinos by gender, sexual orientation and age group has been prepared...
October 7, 2022October 7, 2022
Registration of NLAAD events is open, and HIV testing kits request form available for NLAAD 2022 campaign.
Creating awareness in the Hispanic/Latino Community through events nationwide has been the main goal of NLAAD through the years. Now...
October 5, 2022October 5, 2022
Registrations Open for NLAAD Webinar Series 2022
Tuesday October 4th, 3pm “A different PrEP Option: A Presentation for PrEP Professionals” Apretude is the first and only long...
October 5, 2022October 5, 2022
Launching of National Latino AIDS Awareness Day 2022: “You Choose!”
New York, September 15, 2022- October 15th is National Latinx AIDS Awareness Day (NLAAD). NLAAD’s campaign brings together Hispanic/Latinx communities and...
February 1, 2022October 5, 2023
U.S. FDA Approves CABENUVA for Use Every Two Months, Expanding the Label of the First and Only Long-Acting HIV Treatment
TITUSVILLE, N.J., February 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and...
December 21, 2021October 5, 2023
ViiV Healthcare announces US FDA approval of Apretude, the first and only long-acting injectable option for HIV prevention
London, 21 December 2021 – ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc....
October 18, 2021October 18, 2021
Salud es Vida: “Como encontrar informacion y recursos en Internet sobre el VIH”
October 18, 2021October 18, 2021
Salud es Vida: “Vida Saludable, Peso Saludable y VIH”
October 18, 2021October 18, 2021
Salud es Vida: “Dia Nacional Latino para la Concientizacion sobre el SIDA”
October 18, 2021October 18, 2021